Valuation (19%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.09 | N/A |
| PEG Ratio (TTM) | 0.13 | N/A |
| P/S Ratio (TTM) | 3,116.90 | N/A |
| P/B Ratio (TTM) | 3.22 | N/A |
| P/FCF Ratio (TTM) | -6.44 | N/A |
| Price to 5YR AVG Earnings Ratio | -2.41 | N/A |
| Price to 5YR AVG FCF Ratio | -4.26 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -68.65% | N/A |
| ROE (TTM) | -77.78% | N/A |
| Net Profit Margin (TTM) | -97,516.67% | N/A |
| ROIC 5YR AVG | -3,142.07% | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -434.54% | -65.10% | -1,838.62% |
| Revenue | -25.00% | 12,788.98% | 7,653.39% |
| Net Income | -19.85% | -84.53% | -113.15% |
| Cash Flow | -13.87% | -80.20% | -61.91% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.88 | N/A |
| Quick Ratio (TTM) | 2.88 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -0.02 | N/A |
| Shares Outstanding Growth 5YR AVG | 5.57% | N/A |